Croda International’s consensus price target saw a modest reduction to £35.23 as both future P/E and revenue growth expectations remained stable.
What's in the News
- Croda International is prioritizing organic investment with a focus on higher returns, risk management, and faster cash payback, while reducing CapEx as a percentage of sales from 2026 onwards.
- The company remains committed to growing its dividend.
- Croda plans to pursue modest, technology-led bolt-on acquisitions, with M&A spend limited to a few million pounds.
- Net debt will be maintained within a 1 to 2x EBITDA range, allowing for surplus cash to be returned to shareholders.
- An interim dividend of 48.0 pence per share (totaling £67.0 million) was declared, payable on 7 October 2025.
Valuation Changes
Summary of Valuation Changes for Croda International
- The Consensus Analyst Price Target has fallen slightly from £36.00 to £35.23.
- The Future P/E for Croda International remained effectively unchanged, moving only marginally from 24.58x to 24.18x.
- The Consensus Revenue Growth forecasts for Croda International remained effectively unchanged, at 5.1% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.